Merck logo

Merck

Last updated January 31, 2026
124
Innovation Areas
5,362
Inventors
47
Collaborations

Inadequate kinase signaling selectivity: MerckRecent Research Landscape

Aberrant kinase activity leads to uncontrolled immune cell proliferation and inflammatory responses. Restoring control over these signaling cascades prevents autoimmune progression and oncogenesis.